Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04829188 · ClinicalTrials.gov registry record · NA
Comparative Effectiveness of Readmission Reduction Interventions for Individuals with Sepsis or Pneumonia
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 1,288
- Enrollment target
NCT04829188: Completed NA study, sponsored by University of Pittsburgh.
NCT04829188 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 1,288 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04829188, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,288 participants
- Enrollment target
Study Summary
An adaptive platform trial to compare effectiveness of different care models to prevent readmissions for patients hospitalized with sepsis or lower respiratory tract infection. The primary outcome is number of days spent at home within 90 days after hospital discharge.
Primary Outcome
days alive and at home
Interventions
- BEHAVIORAL Structured Telephone Support (STS)
- BEHAVIORAL Low-intensity Remote Patient Monitoring (RPM-Low)
- BEHAVIORAL High-intensity Remote Patient Monitoring (RPM-High)
- BEHAVIORAL Standard Response Team
- BEHAVIORAL Enhanced Response Team
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,288 participants |
| Start Date | 2021-03-30 |
| Est. Completion | 2024-12-15 |
| Phase | NA |
What the finished NCT04829188 record still lists
NCT04829188 is an interventional study that assigns participants to a tested intervention. Its 1,288 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 5 interventions - of which Structured Telephone Support (STS) is the first listed.
NCT04829188 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04829188 about?
NCT04829188 is a clinical study titled "Comparative Effectiveness of Readmission Reduction Interventions for Individuals with Sepsis or Pneumonia". An adaptive platform trial to compare effectiveness of different care models to prevent readmissions for patients hospitalized with sepsis or lower respiratory tract infection. The primary outcome is number of days spent at home within 90 days after hospital discharge.
What is the current status of trial NCT04829188?
This trial is currently completed. It is a NA study. The enrollment target is 1,288 participants. The study started on 2021-03-30. Estimated completion is 2024-12-15.
What interventions are being tested in trial NCT04829188?
The interventions under investigation include: Structured Telephone Support (STS) (BEHAVIORAL), Low-intensity Remote Patient Monitoring (RPM-Low) (BEHAVIORAL), High-intensity Remote Patient Monitoring (RPM-High) (BEHAVIORAL), Standard Response Team (BEHAVIORAL), Enhanced Response Team (BEHAVIORAL).
Who is sponsoring clinical trial NCT04829188?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04829188's enrollment target sits among peer trials
1,288 78th of 2000 higher than 1,923 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05595642 · 1,290 participants · Phase 3
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
- NCT06626022 · 1,284 participants · Phase 3
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
- NCT05812807 · 1,295 participants · Phase 3
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
- NCT03970447 · 1,280 participants · Phase 2
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI